Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1093951-66-6

2-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine is a pyridine-based chemical compound featuring a boron-containing substituent, commonly utilized as a catalyst in a variety of organic synthesis reactions. Its unique structural and electronic properties render it a valuable reagent in organic chemistry, facilitating important chemical reactions such as cross-coupling and metal-catalyzed transformations. 2-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine is essential for developing novel and efficient synthetic methodologies and holds potential in the pharmaceutical and agrochemical industries for the production of complex organic molecules.

1093951-66-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

  • 2-methoxy-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

    Cas No: 1093951-66-6

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 1093951-66-6 Structure

  • Basic information

    1. Product Name: 2-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine
    2. Synonyms: 2-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine;6-methoxy-4-methyl pyridine-3-boronic acid pinacol ester;2-methoxy-4-methylpyridine-5-boronic acid Pinacol ester
    3. CAS NO:1093951-66-6
    4. Molecular Formula: C13H20BNO3
    5. Molecular Weight: 249.1138
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1093951-66-6.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C
    8. Solubility: N/A
    9. CAS DataBase Reference: 2-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine(1093951-66-6)
    11. EPA Substance Registry System: 2-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine(1093951-66-6)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1093951-66-6(Hazardous Substances Data)

1093951-66-6 Usage

Uses

Used in Organic Synthesis:
2-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine is used as a catalyst for facilitating a range of important chemical reactions in organic synthesis. Its ability to promote cross-coupling reactions and metal-catalyzed transformations makes it a key component in the development of new synthetic methodologies.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine is used as a reagent for the production of complex organic molecules. Its unique properties allow for the synthesis of novel compounds with potential therapeutic applications.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, 2-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine is employed as a reagent for synthesizing complex organic molecules with potential applications in agriculture, such as the development of new pesticides or other agrochemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 1093951-66-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,3,9,5 and 1 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1093951-66:
(9*1)+(8*0)+(7*9)+(6*3)+(5*9)+(4*5)+(3*1)+(2*6)+(1*6)=176
176 % 10 = 6
So 1093951-66-6 is a valid CAS Registry Number.

1093951-66-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-methoxy-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

1.2 Other means of identification

Product number -
Other names RW3589

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1093951-66-6 SDS

1093951-66-6Downstream Products

1093951-66-6Relevant articles and documents

NAPHTHYRIDINE DERIVATIVES AS PRC2 INHIBITORS

-

Paragraph 0335-0336, (2020/11/03)

Disclosed are compounds of formula (I) or (II) that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

IMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES AS PRC2 INHIBITORS FOR TREATING CANCER

-

Paragraph 0276-0277, (2020/12/29)

Disclosed are compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, disclosed are compounds of Formula (I) and pharmaceutical compositions thereof, and methods of using the compounds and pharmaceutical compositions in, for example, methods of treating cancer.

PRC2 INHIBITORS

-

Paragraph 0285-0286, (2019/08/26)

The present invention relates to compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention. (Formula (I))

IMIDAZOPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER

-

Paragraph 00163; 00167, (2018/04/12)

A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R3, R4, R6, and R7 are as defined herein.

TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF

-

Paragraph 0346; 0351; 0355; 0357, (2016/07/27)

A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.

Compounds and Uses Thereof - 848

-

Page/Page column 73; 75, (2009/01/24)

This invention relates to novel compounds having the structural formula I below: and their pharmaceutically acceptable salts, tautomers or in vivo-hydrolysable precursors, compositions and methods of use thereof, wherein R1, R2, Rsu

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1093951-66-6